Lifestyle change and medication for metabolic syndrome
Part of Hormones & metabolism clinical trials.
This trial tests a lifestyle program combined with two medications (semaglutide and dapagliflozin) to help people with metabolic syndrome lose weight and improve their health. It may be an option if you are an adult with a BMI of 27 to 45 and have metabolic syndrome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 65 years old
- Your body mass index (BMI) is between 27 and 45
- You have been told you have metabolic syndrome (a cluster of conditions like high blood sugar, high blood pressure, or unhealthy cholesterol)
- You do not have type 1 or type 2 diabetes that requires medication
- You are not currently taking weight-loss drugs or participating in a weight-loss program
- You can commit to the study for 3 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests weight loss methods in people with type 2 diabetes, high blood pressure, and excess weight. It aims to see if losing 15-20% of body weight can help people live longer and healthier.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This study tests whether semaglutide (a medicine used for diabetes and weight loss) can improve heart health and blood sugar in people with schizophrenia who also have metabolic syndrome. It may help lower the risk of heart problems in this group.
This study tests whether a diabetes medication called an SGLT2 inhibitor can reduce inflammation in body fat and improve blood vessel function in people with metabolic syndrome. It may help prevent heart disease and other complications.
This study tests whether a medication called semaglutide (often used for weight management and diabetes) can improve metabolic health in people with Duchenne muscular dystrophy who are overweight. If you join, you may receive the drug or a placebo, and you'll have health checks including MRIs.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.